about the Event
Peptiligase enzymes offer a scale-able alternative for the large-scale production of long peptides and small proteins.
Recombinant production is not always the solution for producing modest-length proteins (100-150 amino acids), especially when non-canonical and/or branched amino acids are included in the sequence.
Please join our webinar which will focus on some recent syntheses of various small proteins of varying complexity.
Dr. Leendert van den Bos
CEO at EnzyTag BV
Dr. Leendert van den Bos obtained his MSc- and PhD-degree in bio-organic chemistry from Leiden University. In 2007, he joined Organon BioSciences as a Scientist and worked subsequently for Schering-Plough, Merck Sharp & Dohme and Aspen Pharmacare mostly in the field of Process Research & Development. In 2018 he co-founded EnzyTag focusing on the development of chemo-enzymatic processes for complex peptide API’s. Leendert holds an Executive MBA from Nyenrode University.
Business Development Manager at Bachem AG
Seamus White is a Business Development Manager at Bachem Bubendorf. He is located in Northern Ireland and is the primary contact for our partners in the UK and Ireland in the area of GMP peptide API manufacture and development. In his role, he supports our customers through all phases of their project – from preclinical research and IND enabling toxicology studies to process validation and commercialization.
Seamus has been with Bachem since 2020, and prior to this he held positions in Global Procurement, Supplier Management, Lead Auditor and also has API Development and Manufacturing experience with a major Pharma. He has a Bachelor’s degree in Chemistry with Pharmacology and is a chartered Procurement Professional.